Celltrion files IND for phase 3 trial of inhaled Covid-19 cocktail therapy

Celltrion Group (Celltrion Healthcare), a South Korean pharma company, has submitted an investigational new drug (IND) application to carry out a global phase 3 clinical ... Read More